Table 4 Results of cost-effectiveness by trial (1-year) and lifetime time horizons. Mean and 95 % CI presented
Standard | FFR | Incremental | ICER | ||||
|---|---|---|---|---|---|---|---|
Costs (£) | QALYs | Costs (£) | QALYs | Costs (£) | QALYs | (£/QALY) | |
Trial | 7574 (6963–8443) | 0.80 (0.76–0.84) | 7686 (7141–8482) | 0.82 (0.79–0.85) | 112 (−129 to 357) | 0.01 (−0.03 to 0.06) | 7516 |
Lifetime | 10,954 (9482–12,614) | 6.30 (5.07–7.23) | 11,087 (9652–12,699) | 6.33 (5.09–7.25) | 133 (−199 to 499) | 0.03 (−0.21 to 0.28) | 4290 |